Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Phenolic extracts from L. graveolens possess antioxidant and anti-inflammatory properties, significantly inhibiting DPPH radicals and regulating cytokines [PMID:36169085].
L. graveolens infusions and polyphenols-rich extracts showed concentration-dependent antiproliferative effects against MDA-MB-231 and MCF-7 cell lines [PMID:36014479, PMID:41097166].
Ethanolic extract of L. graveolens stem had a favorable effect on biochemical markers in a murine model of metabolic syndrome induced by monosodium glutamate [PMID:36117783].
Methanolic extract of L. graveolens exhibited a photochemopreventive effect against UVB radiation-induced skin cancer in SKH-1 mice [PMID:28039793].
Essential oil and carvacrol show synergistic effects when combined with imipenem against Acinetobacter baumannii and Pseudomonas aeruginosa [PMID:38786172]. It also inhibits A. baumannii biofilm formation [PMID:37887240].
Sécurité et effets indésirables
Interactions médicamenteuses
Synthèse des preuves
Sources PubMed
- 1.PMID: 34500592 (2021) — Mexican Oregano (Lippia graveolens Kunth) as Source of Bioactive Compounds: A Review. · Molecules (Basel, Switzerland)
- 2.PMID: 35012189 (2022) — Polyhydroxyalkanoates-Based Nanoparticles as Essential Oil Carriers. · Polymers
- 3.PMID: 11711112 (1998) — Iridoids from Lippia graveolens. · Phytochemistry
- 4.PMID: 16355848 (2005) — Antifungal activity of Mexican oregano (Lippia berlandieri Shauer). · Journal of food protection
- 5.PMID: 36014479 (2022) — Cytotoxic Activity of Polyphenol Extracts from Three Oregano Species: Hedeoma patens, Lippia graveolens and Lippia palmeri, and Antiproliferative Potential of Lippia graveolens against Two Types of Breast Cancer Cell Lines (MDA-MB-231 and MCF-7).